Economic & Effective Pharmaceutics for Welfare of Patients
We would like to introduce QTO Bimag Pharma as one of the fast-growing Egyptian companies over the past 22 years. QTO Bimag is an Egyptian company specialized in vaccines and pharmaceuticals manufacturing and trading, holding international licenses for pharmaceutical trading.
Our professional staff—all coming with true experience working at multinational pharmaceutical companies such as GSK, Merz, Wyeth, Bayer, Merck, and others—are dedicated to serving customers worldwide through QTO Bimag. We possess extensive experience with the needs of the Egyptian and Middle Eastern markets, alongside strong relations with governmental authorities, the Ministry of Health (MOH), and the private sector.
As official agents for companies worldwide, every solution offered by QTO Bimag Pharma is defined by a "value differential" backed by our outstanding scientific knowledge pool. Our proven capability to market high-value biopharmaceuticals is a true endorsement of QTO Bimag's ability to meet global benchmarks.
QTO Bimag History
Founded in 1997, QTO Bimag Pharma is dedicated
to better health and greater access to health-
care for people
Our route to that target is through deliver products and services conforming to the needs of our customers
Our target is helping people happier lives
Our Advisors visions
College Savings
Insurable risk is predictable
Stocks Management
Obtain highest profit
Investment Advice
Aim all economic activities
Wealth Management
Better proper functioning
Income Insurance
Buying and selling
Industrial Contracts
New and inventive way
TESTIMONIALS
What our customers says?
We have over 15,000 happy customers in world
"Would you like me to give you a formula for success? It's quite simple, really: Double your rate of failure. You are thinking of failure as the enemy of success. But it isn't at all. You can be discouraged by failure or you can learn from it, so go ahead and make mistakes. Make all you can. Because remember that's where you will find success."
"Investors generally expect higher returns from riskier investments. When a low risk investment is made, the return is also generally low. Similarly, high risk comes with high returns. Investors, particularly novices, are often advised to adopt a particular investment strategy and diversify their portfolio."
"Would you like me to give you a formula for success? It's quite simple, really: Double your rate of failure. You are thinking of failure as the enemy of success. But it isn't at all. You can be discouraged by failure or you can learn from it, so go ahead and make mistakes. Make all you can. Because remember that's where you will find success."
37
In finance, the benefit from an investment is called a return. The return may consist of a gain (or loss) realized from the sale of a property or an investment, unrealized capital appreciation, or investment income.
